{"id":"NCT04093024","sponsor":"Boehringer Ingelheim","briefTitle":"A Study to Find Out How Nintedanib is Taken up in the Body and How Well it is Tolerated in Children and Adolescents With Interstitial Lung Disease (ILD)","officialTitle":"A Double Blind, Randomised, Placebo-controlled Trial to Evaluate the Dose-exposure and Safety of Nintedanib Per os on Top of Standard of Care for 24 Weeks, Followed by Open Label Treatment With Nintedanib of Variable Duration, in Children and Adolescents (6 to 17 Year-old) With Clinically Significant Fibrosing Interstitial Lung Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-12-03","primaryCompletion":"2022-05-24","completion":"2022-05-24","firstPosted":"2019-09-17","resultsPosted":"2023-01-31","lastUpdate":"2024-07-09"},"enrollment":39,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Lung Diseases, Interstitial"],"interventions":[{"type":"DRUG","name":"Nintedanib","otherNames":["Ofev®"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Double-blind period (DBP) + open-label Nintedanib period (OLNP): Randomised Nintedanib","type":"EXPERIMENTAL"},{"label":"DBP+OLNP: Randomised placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The main objective of the study is to evaluate dose-exposure and safety of nintedanib in children and adolescents with fibrosing Interstitial Lung Disease (ILD).","primaryOutcome":{"measure":"Area Under the Plasma Concentration-time Curve at Steady State (AUCτ,ss) Based on Sampling at Steady State (at Week 2 and Week 26)","timeFrame":"At Week 2 and at Week 26: at 5 minutes before and at 0, 1, 2, 3, 4, 6, and 8 hours post administration of the morning dose","effectByArm":[{"arm":"DBP+OLNP: 6 to < 12 Years - Exposed to Nintedanib","deltaMin":175,"sd":85.1},{"arm":"DBP+OLNP: 12 to <18 Years - Exposed to Nintedanib","deltaMin":167,"sd":83.6}],"pValues":[]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":19},"locations":{"siteCount":43,"countries":["United States","Argentina","Australia","Belgium","Brazil","Canada","Czechia","Denmark","Finland","France","Greece","Hungary","Italy","Mexico","Norway","Poland","Portugal","Russia","Spain","Ukraine","United Kingdom"]},"refs":{"pmids":["36041751","34164554"],"seeAlso":["https://www.mystudywindow.com"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":13},"commonTop":["Diarrhoea","Nausea","Vomiting","Abdominal pain","Dental caries"]}}